186 related articles for article (PubMed ID: 26998009)
1. Assessment of the redox status in patients with metabolic syndrome and type 2 diabetes reveals great variations.
Spanidis Y; Mpesios A; Stagos D; Goutzourelas N; Bar-Or D; Karapetsa M; Zakynthinos E; Spandidos DA; Tsatsakis AM; Leon G; Kouretas D
Exp Ther Med; 2016 Mar; 11(3):895-903. PubMed ID: 26998009
[TBL] [Abstract][Full Text] [Related]
2. Variations in oxidative stress markers in elite basketball players at the beginning and end of a season.
Spanidis Y; Goutzourelas N; Stagos D; Mpesios A; Priftis A; Bar-Or D; Spandidos DA; Tsatsakis AM; Leon G; Kouretas D
Exp Ther Med; 2016 Jan; 11(1):147-153. PubMed ID: 26889231
[TBL] [Abstract][Full Text] [Related]
3. Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.
Spanidis Y; Stagos D; Orfanou M; Goutzourelas N; Bar-Or D; Spandidos D; Kouretas D
J Strength Cond Res; 2017 Mar; 31(3):582-594. PubMed ID: 28212265
[TBL] [Abstract][Full Text] [Related]
4. Application of a new oxidation-reduction potential assessment method in strenuous exercise-induced oxidative stress.
Stagos D; Goutzourelas N; Bar-Or D; Ntontou AM; Bella E; Becker AT; Statiri A; Kafantaris I; Kouretas D
Redox Rep; 2015 Jul; 20(4):154-62. PubMed ID: 25494543
[TBL] [Abstract][Full Text] [Related]
5. GSH levels affect weight loss in individuals with metabolic syndrome and obesity following dietary therapy.
Goutzourelas N; Orfanou M; Charizanis I; Leon G; Spandidos DA; Kouretas D
Exp Ther Med; 2018 Aug; 16(2):635-642. PubMed ID: 30116319
[TBL] [Abstract][Full Text] [Related]
6. Status of antioxidant and lipid peroxidation in type 2 diabetic human subjects diagnosed with and without metabolic syndrome by using NCEP-ATPIII, IDF and WHO criteria.
Yadav D; Mishra M; Joseph AZ; Subramani SK; Mahajan S; Singh N; Bisen PS; Prasad GB
Obes Res Clin Pract; 2015; 9(2):158-67. PubMed ID: 25890429
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Oxidative Stress in Septic and Obese Patients Using Markers of Oxidation-reduction Potential.
Spanidis Y; Goutzourelas N; Stagos D; Kolyva AS; Gogos CA; Bar-Or D; Kouretas D
In Vivo; 2015; 29(5):595-600. PubMed ID: 26359419
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications.
VanderJagt DJ; Harrison JM; Ratliff DM; Hunsaker LA; Vander Jagt DL
Clin Biochem; 2001 Jun; 34(4):265-70. PubMed ID: 11440725
[TBL] [Abstract][Full Text] [Related]
9. Assessment of eccentric exercise-induced oxidative stress using oxidation-reduction potential markers.
Stagos D; Goutzourelas N; Ntontou AM; Kafantaris I; Deli CK; Poulios A; Jamurtas AZ; Bar-Or D; Kouretas D
Oxid Med Cell Longev; 2015; 2015():204615. PubMed ID: 25874019
[TBL] [Abstract][Full Text] [Related]
10. Oxidative status in ICU patients with septic shock.
Karapetsa M; Pitsika M; Goutzourelas N; Stagos D; Tousia Becker A; Zakynthinos E
Food Chem Toxicol; 2013 Nov; 61():106-11. PubMed ID: 23542126
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
Dave GS; Kalia K
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
[TBL] [Abstract][Full Text] [Related]
12. Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.
Bobe G; Cobb TJ; Leonard SW; Aponso S; Bahro CB; Koley D; Mah E; Bruno RS; Traber MG
Redox Biol; 2017 Aug; 12():121-128. PubMed ID: 28222379
[TBL] [Abstract][Full Text] [Related]
13. Association of hypoglutathionemia with reduced Na+/K+ ATPase activity in type 2 diabetes and microangiopathy.
Sampathkumar R; Balasubramanyam M; Tara C; Rema M; Mohan V
Mol Cell Biochem; 2006 Jan; 282(1-2):169-76. PubMed ID: 16317524
[TBL] [Abstract][Full Text] [Related]
14. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
[TBL] [Abstract][Full Text] [Related]
15. Evidence of Blood and Muscle Redox Status Imbalance in Experimentally Induced Renal Insufficiency in a Rabbit Model.
Poulianiti KP; Karioti A; Kaltsatou A; Mitrou GI; Koutedakis Y; Tepetes K; Christodoulidis G; Giakas G; Maridaki MD; Stefanidis I; Jamurtas AZ; Sakkas GK; Karatzaferi C
Oxid Med Cell Longev; 2019; 2019():8219283. PubMed ID: 31089418
[TBL] [Abstract][Full Text] [Related]
16. Waist circumference is a major determinant of oxidative stress in subjects with and without metabolic syndrome.
Awadallah S; Hasan H; Attlee A; Raigangar V; Unnikannan H; Madkour M; Abraham MS; Rashid LM
Diabetes Metab Syndr; 2019; 13(4):2541-2547. PubMed ID: 31405674
[TBL] [Abstract][Full Text] [Related]
17. High levels of iron status and oxidative stress in patients with metabolic syndrome.
Leiva E; Mujica V; Sepúlveda P; Guzmán L; Núñez S; Orrego R; Palomo I; Andrews M; Arredondo MA
Biol Trace Elem Res; 2013 Jan; 151(1):1-8. PubMed ID: 23079936
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients.
Abou-Seif MA; Youssef AA
Clin Chem Lab Med; 2001 Jul; 39(7):618-23. PubMed ID: 11522108
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and glucose levels in a population-based sample.
Menon V; Ram M; Dorn J; Armstrong D; Muti P; Freudenheim JL; Browne R; Schunemann H; Trevisan M
Diabet Med; 2004 Dec; 21(12):1346-52. PubMed ID: 15569139
[TBL] [Abstract][Full Text] [Related]
20. Systemic oxidative stress in children and teenagers with Down syndrome.
Garlet TR; Parisotto EB; de Medeiros Gda S; Pereira LC; Moreira EA; Dalmarco EM; Dalmarco JB; Wilhelm Filho D
Life Sci; 2013 Oct; 93(16):558-63. PubMed ID: 24004546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
